shutterstock_1770543323_dmitry_kovalchuk
Dmitry Kovalchuk / Shutterstock.com
20 January 2022BiotechnologyMatthew Howell and Lauren Griffin

Pandemic blues: the global approach to COVID-related IP

As the COVID-19 pandemic reaches its two-year anniversary, the world’s battle against the virus continues. But while the world’s attention is (rightly) focused on variants, vaccines and other virus mitigation tools, there are less-reported seismic shifts in the global approach to IP among private companies and governments reacting to COVID-19.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
11 March 2021   The UK has been urged to back a proposed IP waiver related to COVID-19 treatments before the World Trade Organisation by business leaders, academics, economists and trade unions.
Big Pharma
21 July 2022   Global industry body launches declaration | Poorer nations could benefit from more equitable vaccine access | Proposal to be tabled among G7 and G20.
Big Pharma
13 October 2022   The scientist-turned IP specialist chats to LSIPR about why she ‘loves’ the IP sector, her views on policy and funding in science and research, and the cases she’s most proud of.

More on this story

Europe
11 March 2021   The UK has been urged to back a proposed IP waiver related to COVID-19 treatments before the World Trade Organisation by business leaders, academics, economists and trade unions.
Big Pharma
21 July 2022   Global industry body launches declaration | Poorer nations could benefit from more equitable vaccine access | Proposal to be tabled among G7 and G20.
Big Pharma
13 October 2022   The scientist-turned IP specialist chats to LSIPR about why she ‘loves’ the IP sector, her views on policy and funding in science and research, and the cases she’s most proud of.

More on this story

Europe
11 March 2021   The UK has been urged to back a proposed IP waiver related to COVID-19 treatments before the World Trade Organisation by business leaders, academics, economists and trade unions.
Big Pharma
21 July 2022   Global industry body launches declaration | Poorer nations could benefit from more equitable vaccine access | Proposal to be tabled among G7 and G20.
Big Pharma
13 October 2022   The scientist-turned IP specialist chats to LSIPR about why she ‘loves’ the IP sector, her views on policy and funding in science and research, and the cases she’s most proud of.